NOMA
NASDAQ
US
NOMADAR Corp. - Class A Common Stock
$4.24
▼ $-0.16
(-3.64%)
Vol 15K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$68.0M
D/E
20.25
Beta
2.00
52W
$5–$58
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2023-12-31 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -17098.3% | -155.8% | -199.2% | — | — |
| Gross Margin | — | 21.3% | 5.6% | 69.7% | — | — |
| D/E Ratio | — | — | — | 11.80 | — | 20.25 |
| Current Ratio | 19.77 | 0.02 | 0.02 | 0.09 | — | 0.06 |
Key Ratios
52W High
$57.70
52W Low
$4.88
$4.88
52-Week Range
$57.70
How does NOMA compare to Media peers?
Peer group: Micro-cap Media (All) · 182 companies
NOMA valuation vs Media peers
P/E ratio
—
▼
0%
below
peers
(17.2)
vs Peers
vs Industry
Fair value
P/S ratio
—
▼
0%
below
peers
(0.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(1.6)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.3%)
vs Peers
vs Industry
Low yield
NOMA profitability vs Media peers
ROE
—
▼
0%
below
peers
(-2.8%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-2.5%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(52.3%)
vs Peers
vs Industry
Top tier
ROA
—
▼
0%
below
peers
(-2.5%)
vs Peers
vs Industry
Top tier
NOMA financial health vs Media peers
D/E ratio
20.3
▼
10%
below
peers
(22.5)
vs Peers
vs Industry
In line
Current ratio
0.1
▼
95%
below
peers
(1.4)
vs Peers
vs Industry
Low liquidity
Beta
2.0
▲
96%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
NOMA fundamentals radar
NOMA
Peer median
Industry
NOMA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NOMA vs peers: key metrics
Latest News
The problem goes far beyond Noma – I’ve seen rot creeping into …
The Guardian · Mar 29
Williams-Sonoma Just Raised Its Dividend 15%. Should You Buy the Blue-Chip Stock …
Yahoo Finance · Mar 27
Nomad Foods (NOMD) is One of the Best Small Cap Consumer Staples …
Yahoo Finance · Mar 24
Why Williams-Sonoma Could Be One of Retail’s Smartest Long-Term Buys
Yahoo Finance · Mar 23
Analyst Sentiment Remains Strong on Iovance Biotherapeutics (IOVA) Amid U.S. Rollout of …
Yahoo Finance · Mar 22